EurON: Eurofarma's new digital innovation brand connects people,
science and technology
The platform speeds up the digital transformation of the healthcare ecosystem and the first initiative is the opening of the connection to startup program
São Paulo, September 11, 2023 – Eurofarma, a multinational Brazilian pharmaceutical company present in 22 countries, announces a new brand for the company's entrepreneurship and digital transformation platform. EurON was designed to be a strong and unique brand, created to convey all the Eurofarma initiatives and digital platforms in a synergistic way, translating the fluid and collaborative connection between the company and the digital universe.
Society is already in the era of accelerated health transformation. Breakthroughs that took a generation to unfold are achieved faster and faster or in instants. Eurofarma knows that the direction of this change is what will make the world better. And by looking up to the sky and keeping its feet on the ground, the company, through its legacy and DNA of constant evolution, presents EurON, a new space for innovation in a collaborative environment, given that innovation at Eurofarma is life being expanded. People, science and technology in a new synergy, enabling a future of global and affordable health.
The new EurON brand brings together:
- EurON Six Sigma, the area responsible for intra-entrepreneurship projects, which empowers employees to take a critical eye to develop solutions that bring efficiency to the current process, as well as to transform processes and business models with innovative solutions.
- EurON Open Innovation, the area responsible for exploring business opportunities aligned with Eurofarma's strategy and in synergy with the innovation ecosystems of Latin America, and creating an inbound flow for EurON Ventures. One of the fronts is the startup connection program.
- EurON Digital Health, a business unit with a global scope focused on generating value and revenue through digital technology solutions. A Digital Health area that develops projects such as the award-winning Scrolling Therapy application, which uses artificial intelligence to navigate social networks through facial movements, as a support therapy for Parkinson's patients.
- EurON Ventures is an investment fund focused on technology projects aimed at the healthcare sector, which are at an early stage and focused on sorting out relevant issues in the sector.
- EurON Data, a Market Intelligence and Data area that will provide relevant and actionable insights to support and influence the company's strategic decisions.
"After celebrating 50 years of history, we translated the language and structure of all initiatives in Eurofarma's entrepreneurship and digital area into a name that reflects the fluid and collaborative connection between Eurofarma and the digital universe. We are unifying this digital transformation to consolidate the company's position and importance in this ecosystem, thus positioning Eurofarma as a synergy agent between people, science and technology for more life and health through the legacy and DNA of innovation," says Rodrigo Pereira, executive director of Entrepreneurship & Digital at the company.
To foster the culture of innovation at Eurofarma, there are also new digital platforms: EurOn News, newsletters that will bring relevant content on digital innovation; EurON Talks, which will be activations with guests references in themes regarding innovation and technology; EurON Academy, a new digital innovation education platform; and EurON Hub, a new location for collaborative innovation.
The EurON Open Innovation has premiered by launching the connection program for Latin American startups
Applications for the startup connection program are open and will continue so by 10.06. The program is aimed at startups from all over Latin America that already have a validated product and are in the traction and scale phase.
"We are looking for companies willing to test their solution through a paid pilot and by leveraging it through contact with information and trends in the health sector, coaching in business areas and access to Eurofarma's relationship network, with over 4,000 suppliers, 1,500 active customers (B2B) and about 500,000 medical contacts per month, in addition to the chance of a long-term partnership with Eurofarma," comments Rodrigo Pereira.
Eurofarma is one of the pharmaceutical companies that invest the most in innovation in Latin America. The program has been a success since it was created in 2018. To date, the pioneering program in the pharmaceutical sector for startup acceleration has had more than 1,500 companies registered, and more than 70 accelerated, of which more than 50 have already carried out pilot projects and more than 50% have signed a contract with the company.
The methodology and mentoring of the program allow startups to perceive points of attention and improvements, as well as the actual potential of the solution, also exploring other possible fronts not seen until then.
It is worth mentioning that even if the startup originates from one country, it may present a solution to be implemented in another region, provided that it complies with the requirements established in the regulation.
Check out the challenges involving the Eurofarma’s Startups connection program:
| Region | Challenge | Summary |
| Latam | Digital twin of production line | We are looking for a technological solution (such as a digital twin) that enables real-time consolidation and visualization of relevant production data. |
| Latam | Mapping and Control of Risks in Labor Tasks | We are looking for a partner who will help us revisit and parameterize the processes to establish risks in the manufacturing environment and who has a technological solution that helps maintain the subsequent safety control in the factories. |
| Latam | Machine scanning for OEE control | We seek a technological solution that automates the control of OEE through IoT sensors and data processing. |
| Latam | Predictive maintenance | We seek to implement a two-stage predictive maintenance solution. In the first stage, a predictive monitoring system for electrical panels and manipulators is proposed. In the second stage, the implementation of a monitoring system of the syrups production lines is proposed. |
| Latam | Automation of Packing Lists | We are looking for a technological solution that automates the process of creating packing lists. |
| Latam | Support for patients with chronic diseases | We seek solutions that involve physicians and patients, which are in accordance with the Eurofarma values (Focus on Health, Ethics, Innovation). |
| Latam | Intelligence Tools for Sales Reps | We look for ways to personalize the offer to physicians, saving them time and helping them get the most out of our medications and treatments. |
| Latam | Digital transformation for independent pharmacies | We seek to be technological partners of independent pharmacies, helping them in their digital transformation journey and providing them with management tools relevant to their business. |
| Brazil | Consolidation and monitoring of strategic indicators | We seek a platform where the management and monitoring of indicators can be carried out, bringing an agile and spot-on visibility regarding the fulfillment of the strategic vision. |
| Brazil | Automation of customer registration | We seek an automation that consults public data and automatically feeds the necessary information to register new customers in our ERP. |
| Brazil | Automation of the credit analysis process | We seek an automation for the credit analysis process, which performs queries of public data, payment history in our ERP and calculates risk and credit limit based on this information and defined parameters. |
| Brazil | Automation of the registration and approval of suppliers | We seek an automation that consults public data and automatically feeds the required information to register new suppliers in our ERP. |
| Brazil | Artificial intelligence for comparative and document conferencing | We seek an intelligence for evaluation and comparison of different files. The idea is that technical analysts validate the document only once and from then on, the automation checks the data in the next steps of the process. |
| Brazil | Consolidation of fleet management data | We seek a platform for consolidating and managing the data of our own and leased fleets in both Brazil and Latin America. |
| Brazil | Follow-up of the cancer patient's journey | We seek to develop a follow-up of the oncology patient's journey along with their clinical record, thus offering guidance on treatment, awareness of side effects and support. |
In order to get to know everything about the program, to learn about stories of those who have already been part of it and to register for the new edition of the program, please visit euroneurofarma.com
About Eurofarma
Founded in 1972, Eurofarma operates in the health sector by producing and marketing products and services to improve people's quality of life. With a focus on generating shared value, it covers all major pharmaceutical segments, such as Medical Prescription, Generics, OTC, Hospital and Oncology. With a broad coverage of therapeutic classes, the portfolio in the region comprises 2,800 SKUs and serves 42 medical specialties. Present in 22 countries, primarily in Latin America, it also maintains operations in the USA and Africa. With more than 11,000 employees, in 2022 it was registered as a publicly-held company with the Brazilian Securities and Exchange Commission (CVM). It reported R$ 8 billion in net revenue, a 13.3% growth over the previous year, with R$ 2 billion in ebitda, an increase of 20%. In R&D, investments in the year totaled over R$ 590 million, equivalent to 7.4% of net revenue.
Euron on social networks
Instagram: @euron.eurofarma | @euron.eurofarma.es
Eurofarma on social networks
Facebook: @eurofarma | LinkedIn: @eurofarma
Instagram: @eurofarma
Youtube: @eurofarmalab
Press Information
G&A Public Relations
Luciana Lima - +55 11 98596-9601 – luciana.lima@gaspar.com.br
Sarah Cardoso - +55 11 94821-0883 – sarah.cardoso@gaspar.com.br
Guilherme Gaspar - +55 11 98285-6000 – guilherme@gaspar.com.br